Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/MINERVA-NEUROSCIENCES-INC-16772158/news/Minerva-Neurosciences-Announces-the-NDA-Filing-for-Roluperidone-for-the-Treatment-of-Negative-Sympto-43700863/?utm_source=whatsapp&utm_medium=social&utm_campaign=share